June 2020 | Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain
May 2020 | Poxel Announces Program Update and Preclinical Results on PXL770 for NASH Combinations and Other Metabolic Diseases
Apr. 2020 | Adocia announces positive topline results of the exploratory Phase 1b study of ADO09 (M1Pram) in people with type 1 diabetes
Apr. 2020 | Poxel Announces Publication of Imeglimin Clinical Study Results in Clinical Pharmacokinetics
Oct. 2019 | Adocia obtains additional financial resources from IPF Partners for a maximum amount of €15m
